Medical Device General Discussion

Aerin Medical

3 days ago

The clinical results and patient reported outcomes are looking great. Small capital investment from the ENT with minimal patient risk. All they need is more market exposure and with a huge presence at at AAO in September, things are looking very promising.

Looking to Leave Medical Device Sales

2 weeks ago

I took a good look at this a few years back. Unless you are dialed in on an opportunity, it’s tough to make a lateral move into a new sector. There are definitely lucrative sales jobs out there, but they seldom go to an industry rookie. A lot of B2B sales jobs are pretty travel-intensive as well.

Vapotherm Sales Rep

3 weeks ago

What is this company like to work for? East Coast territory. And what is the realistic first year pay? Thx.

FDA Grants Fast Track Designation for FARXIGA in Heart Failure

13 hours ago

AstraZeneca today announced that the US Food and Drug Administration (FDA) has granted Fast Track designation for the development of FARXIGA (dapagliflozin) to reduce the risk of cardiovascular (CV) death or the worsening of heart failure in adults with heart failure with reduced ejection fraction (HFrEF) or preserved ejection fraction (HFpEF).

Robotic Surgery and Shadow Learning Making Surgeon Trainees Bad at Surgery

5 months ago

Considering how many surgeries are moving towards robotic techniques, it's scary to think about how little experience some residents will have if robotic surgery becomes the standard of care in most specialties.

Levita Magnetics

2 months ago

Next big startup in medical device.

Intact Vascular to Announce One-Year Data from TOBA III Clinical Trial

13 hours ago

​Intact Vascular, Inc., a developer of medical devices for minimally invasive peripheral vascular procedures, today announced that the one-year data from its Tack Optimized Balloon Angioplasty (TOBA) III clinical trial will be presented during the High Impact Clinical Research session of the 31st

Hey Everyone I need your advice for my invention

3 months ago


I have recently received a provisional patent for a stool that attaches to a kitchen sink. I came up with the idea after hearing my mother complain in the kitchen that it hurt her back to do dishes. As an avid inventor my mind started spinning immediately on how to make it comfortable for her to clean her dishes without pain and able to just fold up the stool walk away till the next time. I came up with and patented:

1) A stool that stays at the kitchen sink and folds up when not in use.
2) …

John Oliver Takes on the Medical Device Industry

3 months ago

The 510(k) process is the focus of his argument --

In order to avoid stifling innovation, the FDA created a system called the 501(k) pathway, which allowed companies to avoid thorough testing for devices that are “substantially similar to one that had come before.” But this also created a dangerous loophole: As of 2017, Oliver reported, over 80 percent of medical devices are cleared through that system, including around 400 implanted devices per year. In this diluted process, products can be …

Medical Device Recruiters

4 months ago

A number of them have of never had a discussion with a physician about what's important to them in a customer driven sales consultant, much less ever even seen the inside of an ASC or an OR. Yet, they have all the capabilities and intuitiveness to determine what successful reps, Directors, VP's and CEO's do to become successful??? Crazy! And no, I am not against GOOD, CREDIBLE recruiters. I do believe there are good ones and have used them routinely. But, dig deep and look at previous place…

National Lipid Association’s New Position Statement on Use of Icosapent Ethyl in High and Very-High-Risk Patients Recognizes Importance of Addressing Residual Cardiovascular Risk in Patients on Statins

14 hours ago

​Amarin Corporation plc (NASDAQ: AMRN), a pharmaceutical company focused on improving cardiovascular health, today announced that the National Lipid Association (NLA) has issued a position statement recognizing the cardiovascular risk-lowering effects of icosapent ethyl based on the landmark REDUCE-IT cardiovascular outcomes study.

CoreLink Surgical

4 months ago

Has anyone seen CoreLink's Lateral Access System in a case?

Medical device company CoreLink Surgical launched its Lateral Access System and two implant systems — the F3D and CL5 Lateral interbody fusion devices — designed for lateral fusions, reports Business Wire.

Four things to know:

1. The F3D Lateral implant uses CoreLink uses 3D printing and finishing methods to develop the Mimetic Metal technology, which has a trabecula structure with interconnected 500-micron pores.

2. The implant is fus…

Celgene Announces Phase 3 QUAZAR AML-001 Study of CC-486 as Maintenance Therapy in Patients With Newly Diagnosed Acute Myeloid Leukemia Met Primary and Key Secondary Endpoints

3 days ago

Celgene Corporation (NASDAQ: CELG) today announced top-line results from the international phase 3, randomized, double-blind, placebo-controlled study, QUAZAR AML-001. The study evaluated the efficacy and safety of investigational therapy CC-486 as maintenance therapy in patients with newly diagnosed acute myeloid leukemia (AML)

The Sunshine Act

5 months ago

It is accurate now, maybe not when it came out though.